Pharmafile Logo

Souvenaid

- PMLiVE

Being social – harnessing the power of social media

With around 2.8 billion people using social media today, it’s a powerful force – one that encompasses a broad spectrum of websites and applications. In addition to well-known websites like Facebook,...

Porterhouse Medical Group

- PMLiVE

Ionis must go it alone as GSK ditches polyneuropathy drug

Inotersen’s side effects prompts pharma giant to relinquish rights

- PMLiVE

NICE expands Merck KGaA’s Erbitux reach

Backs the medicines use for patients with SCCHN

- PMLiVE

Righting pharma’s reputational wrongs

Addressing the issues of transparency in pharma

- PMLiVE

Ditch the data?

Looking beyond the data

Celgene building

Celgene steps back from $1bn Sutro acquisition

Instead opts for amended licensing deal with US biotech

- PMLiVE

Biotecnol taps into Cancer Research UK network for first trial

New drug hoped to have broad activity across multiple tumour types

- PMLiVE

Leading Edge bolsters its delivery team

After earlier announcements that Lucid Partners was growing its medical writing team, Leading Edge (a Lucid Group company) proudly announces that it is strengthening its delivery team.Francesca Worthington joined Leading Edge...

Lucid Group Communications Limited

- PMLiVE

Biogen expands digital safety platform Assessa

The MS technolgy pilot, a collaboration with Ixico, will now include pharmacoviglance reporting

- PMLiVE

Forming a picture of health

As life expectancy increases how can stakeholders ensure the last decades of life are healthy ones?

- PMLiVE

The Foundry Healthcare appoints new head

Gerry Montgomery joins as head of healthcare

- PMLiVE

Roivant gets $1.1bn investment from Japan’s SoftBank

The fund will launch new subsidiaries, says the biotech

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links